IDEAYA Biosciences Announces Phase 1 2 Expansion for IDE397 and Trodelvy R Combination in MTAP Deletion Urothelial Cancer

Thursday, April 10, 2025 1 min read

Key Takeaway: IDEAYA Biosciences Announces Phase 1 2 Expansion for IDE397 and Trodelvy R Combination in MTAP Deletion Urothelial Cancer

Full Press Release Details

IDEAYA Biosciences Announces Phase 1 2 Expansion for IDE397 and Trodelvy R Combination in MTAP Deletion Urothelial Cancer.